Benjamin M Scirica Selected Research

aclidinium bromide

10/2021	Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial.
1/2021	The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial.
1/2019	Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
1/2018	Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin M Scirica Research Topics

Disease

89	Myocardial Infarction 02/2024 - 11/2003
56	Acute Coronary Syndrome 01/2021 - 11/2003
43	Heart Failure 02/2024 - 06/2006
31	Ischemia 01/2021 - 02/2006
30	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2011
29	Hemorrhage 01/2020 - 10/2006
25	Diabetes Mellitus 01/2022 - 04/2009
23	Stroke (Strokes) 12/2019 - 09/2009
19	Peripheral Arterial Disease 02/2024 - 09/2009
19	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2009
19	ST Elevation Myocardial Infarction 01/2018 - 07/2006
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 02/2007
14	Atherosclerosis 08/2022 - 09/2009
13	Ischemic Stroke 02/2024 - 09/2009
10	Thrombosis (Thrombus) 01/2020 - 10/2006
9	Heart Arrest (Cardiac Arrest) 01/2022 - 12/2010
8	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 02/2007
7	Non-ST Elevated Myocardial Infarction 01/2018 - 10/2007
6	Atrial Fibrillation 01/2023 - 01/2015
6	Hypertension (High Blood Pressure) 01/2023 - 07/2012
6	Chronic Renal Insufficiency 01/2021 - 06/2014
6	Unstable Angina 01/2018 - 10/2007
5	Albuminuria 01/2022 - 04/2015
5	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 01/2018
5	Overweight 01/2019 - 01/2018
5	Renal Insufficiency (Renal Failure) 01/2018 - 11/2003
5	Transient Ischemic Attack 03/2017 - 12/2014
4	Chest Pain (Chest Pains) 10/2023 - 02/2014
4	Cardiomyopathies (Cardiomyopathy) 01/2023 - 04/2016
4	Ventricular Tachycardia 01/2021 - 08/2010
4	Infections 01/2021 - 06/2006
4	Weight Loss (Weight Reduction) 01/2019 - 01/2018
4	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 04/2009
4	Cardiac Arrhythmias (Arrythmia) 02/2017 - 04/2007
4	Vascular Diseases (Vascular Disease) 12/2014 - 07/2012
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 08/2010
3	Coma (Comas) 12/2018 - 12/2010
3	Bradycardia 01/2018 - 05/2011
3	Cardiogenic Shock 04/2016 - 05/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2014 - 04/2012
2	Obesity 12/2023 - 01/2021
2	Kidney Diseases (Kidney Disease) 10/2023 - 01/2018
2	Diarrhea 01/2021 - 11/2010
2	Body Weight (Weight, Body) 10/2019 - 10/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 12/2014
2	Pathologic Constriction (Stenosis) 03/2016 - 04/2010

Drug/Important Bio-Agent (IBA)

24	vorapaxarIBA 08/2022 - 09/2009
24	Ranolazine FDA Link 01/2021 - 06/2006
23	Neurofibromin 2 (Merlin)IBA 01/2021 - 06/2006
22	saxagliptin FDA Link 11/2021 - 11/2011
19	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2003
18	Clopidogrel (Plavix)FDA Link 01/2020 - 07/2006
13	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 02/2007
12	TroponinIBA 10/2023 - 11/2003
10	omega-Chloroacetophenone (Mace)IBA 02/2024 - 05/2011
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2009
9	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
9	TicagrelorIBA 01/2021 - 11/2007
8	Natriuretic PeptidesIBA 12/2023 - 08/2010
8	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 03/2011
8	dapagliflozinIBA 10/2023 - 10/2019
8	SodiumIBA 01/2022 - 06/2006
6	C-Reactive ProteinIBA 02/2024 - 10/2007
6	Troponin T (Troponin T1)IBA 11/2021 - 11/2003
5	CreatinineIBA 10/2023 - 03/2013
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 11/2010
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
5	lorcaserinIBA 01/2019 - 01/2018
4	AlbuminsIBA 10/2023 - 01/2018
4	LipidsIBA 01/2023 - 01/2021
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2022 - 09/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2006
4	aclidinium bromideIBA 10/2021 - 01/2018
4	Insulin (Novolin)FDA Link 01/2021 - 04/2015
4	Troponin IIBA 01/2021 - 03/2011
4	Thrombin FDA Link 10/2019 - 09/2009
4	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
4	Heparin (Liquaemin)FDA LinkGeneric 11/2010 - 10/2006
3	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2021
3	Muscarinic AntagonistsIBA 10/2021 - 01/2019
3	Prasugrel Hydrochloride FDA Link 01/2020 - 04/2008
3	Peptide Hydrolases (Proteases)FDA Link 03/2017 - 04/2013
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017 - 11/2011
3	CalciumIBA 10/2007 - 06/2006
3	MB Form Creatine KinaseIBA 02/2007 - 11/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023 - 01/2021
2	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2017
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 08/2016
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2019
2	empagliflozinIBA 12/2019 - 11/2017
2	PotassiumIBA 02/2017 - 01/2012

Therapy/Procedure

50	Therapeutics 02/2024 - 03/2005
16	Secondary Prevention 10/2021 - 10/2012
15	Percutaneous Coronary Intervention 01/2020 - 10/2006
8	Induced Hypothermia 01/2022 - 12/2010
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2017 - 09/2009
4	Stents 01/2020 - 04/2008
2	Glycemic Control 01/2017 - 11/2011
2	Resuscitation 05/2016 - 12/2010